Please select the option that best describes you:

How would you approach a patient over the age of 40 with a sub-totally resected frontal oligodendroglioma, WHO Grade II, 1p/19q co-deleted, IDH mutant, with imaging concerning for second site in the pontomedullary junction?   



Answer from: Radiation Oncologist at Academic Institution
Comments
Radiation Oncologist at Oncology Nevada
Isn’t Vorasidenib just palliative? It seems ...
Radiation Oncologist at University of Arizona
Yes, Vorasidenib is not curative. However, in thi...
Radiation Oncologist at Oncology Nevada
@Baldassarre Stea, really appreciate the thoughtfu...
Sign in or Register to read more